Perinatal single-hormone treatment causes hormonal imprinting with lifelong consequences in receptor-binding capacity, hormone production as well as in social and sexual behavior. In the present experiments, newborn rats were treated with a single dose of oxytocin, and the levels of biogenic amines and their metabolites were studied in 8 different brain regions and in the sera when the male and female animals were 4 months old. Both dopaminergic and serotonergic neurotransmission was found to be significantly influenced. The levels of 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole acetic acid metabolites decreased in the hypothalamus and striatum. Dopamine, serotonin, norepinephrine, and 5-hydroxytryptophol levels were hardly altered, and there was no difference in the epinephrine levels. The results show that dopamine and serotonin metabolism of hypothalamus and striatum are deeply and lifelong influenced by a single neonatal oxytocin treatment Oxytocin imprinting resulted in decreased dopamine turnover in the hypothalamus and decreased serotonin turnover in the hypothalamus, medulla oblongata, and striatum of females. As the disturbance of brain dopamine and serotonin system has an important role in the development of pervasive developmental diseases (eg, autism) and neuropsychiatric disorders (eg, schizophrenia), the growing number of oxytocin-induced labor as a causal factor, cannot be omitted.
CsabaG. Phylogeny and ontogeny of hormone receptors: the selection theory of receptor formation and hormonal imprinting. Biol Rev. 1980;55(1):47–63.
2.
CsabaG. Hormonal imprinting: its role in the evolution and development of hormones and receptors. Cell Biol Int. 2000;24(7):407–414.
3.
TchernitchinATchernitchinN. Imprinting of heterodifferentation by prenatal or perinatal exposure to hormones, pharmaceuticals, pollutants and other agents and conditions. Med Sci Res. 1992;20:391–397.
4.
CsabaG.Hormonal imprinting: phylogeny, ontogeny, diseases and possible role in present-day human evolution. Cell Biochem Funct. 2008;26(1):1–10.
5.
CsabaG.The present state in the phylogeny and ontogeny of hormone receptors. Horm Metab Res. 1984;16(7):329–335.
6.
CsabaGInczefi-GondaÁDobozyO. Hereditary transmission to the F1 generation of hormonal imprinting (receptor memory) induced in rats by neonatal exposure to insulin. Acta Physiol Hung. 1984;63(2):93–99.
7.
CsabaGNagySU. Influence of the neonatal suppression of TSH production (neonatal hyperthyroidism) on response to TSH in adulthood. J Endocrinol Invest. 1985;8(6):557–559.
8.
CsabaG. The biological basis and clinical significance of hormonal imprinting, an epigenetic process. Clin Epigenet. 2011;2(2):187–196.
9.
CsabaGTekesK. Is the brain hormonally imprintable?Brain Dev. 2005;27(7):465–471.
10.
CsabaGKnippelBKarabélyosCInczefi-GondaÁHantosMTekesK. Impact of single neonatal serotonin treatment (hormonal imprinting) on the brain serotonin content and sexual behavior of adult rats. Life Sci. 2003;73(21):2703–2711.
11.
CsabaGKnippelBKarabélyosCEffect of neonatal beta-endorphin imprinting on sexual behavior and brain serotonin level in adult rats. Life Sci. 2003;73(1):103–114.
12.
TekesKGyengeMSótonyiPCsabaG. Effect of neonatal nociceptin or nocistatin imprinting on the brain concentration of biogenic amines and their metabolites. Brain Dev. 2009;31(4):282–287.
13.
TekesKGyengeMFolyovichACsabaG. Influence of neonatal vitamin A or vitamin D treatment on the concentration of biogenic amines and their metabolites in the adult rat brain. Horm Metab Res. 2009;41(4):277–280.
14.
TekesKGyengeMHantosMCsabaG.Transgenerational hormonal imprinting caused by vitamin A or vitamin D treatment of newborn rats. Alterations in the biogenic amine content of the adult brain. Brain Dev. 2009;31(9):666–670.
15.
TekesKSzegiPLauferRHantosMCsabaG. Effect of perinatal stress on the biogenic amine neurotransmitter level of the adult rat’s brain. Int J Dev Neurisci. 2011;29(2):171–175.
16.
TekesKGyengeMHantosMCsabaG. Effect of beta-endorphin imprinting during late pregnancy on the brain serotonin and plasma nocistatin levels of adult male rats. Horm Metab Res. 2007;39(7):479–481.
17.
CsabaGKnippelBKarabélyosCInczefi-GondaÁHantosMTekesK. Endorphin excess at weaning durably influences sexual activity, uterine estrogen receptor binding capacity and brain serotonin level of female rats. Horm Metab Res. 2004;36(1):39–43.
18.
PlotheC.The perinatal application of oxytocin and its potential influence on the human psyche. Prenatal Perinatal Psychol Med. 2009;21(3/4):181-198.
19.
CarterCS. Developmental consequences of oxytocin. Physiol Behav. 2003;79(3):383–397.
20.
KramerKMCushingBSCarterCS. Developmental effects of oxytocin on stress response: single versus repeated exposure. Physiol Behav. 2003;79(4-5):775–782.
21.
ModiMEYoungLJ. The oxytocin system in drug discovery for autism: animal models and novel therapeutic strategies. Horm Behav. 2012;61(3):340–350.
22.
BalesKLAbdelnabiMCushingBSOttingerMACarterCS. Effects of neonatal oxytocin manipulations on male reproductive potential in prairie voles. Physiol Behav. 2004;81(3):519–526.
23.
BalesKLvan WesterhuyzenJALewis-ReeseADGrotteNDLanterJACarterCS. Oxytocin has dose-dependent developmental effects on pair-bonding and alloparental care in female prairie voles. Horm Behav. 2007;52(2):274–279.
24.
BalesKLCarterCS. Developmental exposure to oxytocin facilitates partner preferences in male prairie voles (Microtus ochrogaster). Behav Neurosci. 2003;117(4):854–859.
25.
EatonJLRoacheLNguyenKNOrganizational effects of oxytocin on serotonin innervation. Dev Psychobiol. 2012;54(1):92–97.
26.
WallaceLjTraegerJS.DOPAC distribution and regulation in striatal dopaminergic varicosities and extracellular space. Synapse. 2012;66(2):160–173.
27.
RevinSBJohnSA. Simultaneous determination of two important dopamine metabolites at physiological pH by voltammetry. Anal Methods. 2012;4(2):348–352.
28.
HornykiewiczO. Brain monoamines and parkinsonism. Natl Inst Drug Abuse Res Monogr Ser. 1975;3:13–21.
29.
SandykRIaconoRPBamfordCR. The hypothalamus in Parkinson disease. Ital J Neurol Sci. 1987;8(3):227–234.
30.
MuthianGMackeyVKingJCharltonCG. Modelling a senzitization stage and a precipitation stage for Parkinson’s disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. Neuroscience. 2010;169(3):1085–1093.
31.
WyattRJKaroumFCasanovaMF. Decreased DOPAC in the anterior cingulate cortex of individuals with schizophrenia. Biol Psychiatry. 1995;38(1):4–12.
32.
SharmaRPJavaidJLDavisJMJanicakPG. Pretreatment plasma homovanillic acid in schizophrenia and schizoaffective disorder: the influence and inpatient drug-free period. Biol Psychiatry. 1998;44(6):488–492.
33.
StanleyBMolchoAStanleyMAssociation of aggressive behavior with altered serotonergic function in patients who are not suicidal. Am J Psychiatry. 2000;157(4):609–614.
34.
MehlmanPTHigleyJDFaucherILow CSF 5-HIAA concentrations and severe aggression and impaired impulse control in nonhuman primates. Am J Psychiatry. 1994;151(10):1485–1491.
35.
BaskervilleTADouglasAJ. Dopamine and oxytocin interactions underlying behaviors: potential contributions to behavioral disorders. CNS Neurosci Ther. 2010;16(3):e92–e123.
36.
SkuseDHGallagherL. Dopaminergic-neuropeptide interactions in the social brain. Trends Cogn Sci. 2009;13(1):27–35.
37.
GreenJJHollanderE. Autism and oxytocin: new developments in transitional approaches to therapeutics. Neurotherapeutics. 2010;7(3):250–257.
38.
LeeHJMacbethAHPaganiJHYoungWS. Oxytocin: the great facilitator of life. Prog Neurobiol. 2009;88(2):127–151.
39.
HaronyHWagnerS. The contribution of oxytocin and vasopressin to mammalian social behavior: potential role in autism spectrum disorder. Neurosignals. 2010;18(2):82–97.
40.
CosgroveKPMazureCMStaleyJK. Evolving knowledge of sex differences in brain structure and chemistry. Biol Psychiatry. 2007;62(8):847–855.
41.
CarterCS. Sex differences in oxytocin and vasopressin: implications for autism spectrum disorders. Behav Brain Res. 2007;176(1):170–186.
MoletiCA. Trends and controversies in labor induction. MCN Am J Matern Child Nurs. 2009;34(1):40–47.
44.
MackenzieIZ. Induction of labour at the start of the new millenium. Reproduction. 2006;131(6):989–998.
45.
NewschafferCJCroenLADanielsJThe epidemiology of autism spectrum disorders. Annu Rev Public Health. 2007;28:235–258.
46.
KeyesKMSusserECheslak-PostavaKFountainCLiuKBearmanPS. Cohort effects explain the increase in autism diagnosis among children born from 1992 to 2003 in California. Int J Epidemiol. 2011;41(2):495–503.
47.
Pinborough-ZimmermanJBilderDSatterfieldRHossainSMcMahonW. The impact of surveillance method and record source on autism prevalence: collaboration with Utah Maternal and Child Health programs. Matern Child Health J. 2010;14(3):392–400.
48.
WahlRU. Could oxytocin administration during labor contribute to autism and related behavioral disorders? – A look at the literature. Med Hypotheses. 2004;63(3):456–460.
49.
CsabaG.Thoughts on the cultural evolution of man. Developmental imprinting and transgenerational effect. Riv Biol. 2007;100(3):461–474.
50.
AngelidouAAsadiSAlysandratosKDKaragkouniAKourembanasSTheoharidesTC. Perinatal stress, brain inflammation and risk of autism – review and proposal. BMC Pediatr. 2012;12:89.
51.
KosakaHMunesueTIshitobiMLong-term oxytocin administration improves social behaviors in a girl with autistic disorder. BMC Psychiatry. 2012;12:110.
52.
MatsuzakiMMatsushitaHTomizawaKMatsuiH. Oxytocin: a therapeutic target for mental disorders. J Physiol Sci. 2012;62(6):441–444.
